Halozyme Therapeutics Inc

NASDAQ: HALO
$37.81
-$0.21 (-0.6%)
Closing price April 18, 2024
Halozyme Therapeutics Inc is a biopharmaceutical company that specializes in developing and commercializing innovative enzyme-based therapies. Utilizing its patented recombinant human hyaluronidase enzyme (rHuPH20), Halozyme enhances the delivery of injectable biologics, including monoclonal antibodies and other therapeutic molecules. Its product lineup addresses a variety of medical conditions, from hydration and drug dispersion to treating chronic diseases such as HIV, multiple sclerosis, and various cancers. Founded in 1998, Halozyme is headquartered in San Diego, California, serving a global market.
Stocks are looking for their footing after having hit new all-time highs in the prior week. Volatility has returned, but investors are looking at individual stock picks rather than just trying to...
Source: ThinkstockStocks have pulled back from their all-time highs after escalation of civil war in Iraq, but Friday managed to close higher. Investors remain bullish, and they keep hearing that the...
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 12, 2014. They include Apache, Apple, Hewlett-Packard, Qualcomm and Sprouts Farmers Market.
Halozyme Therapeutics saw its stock surge on Thursday on news reports that the FDA has removed its clinical hold on patient enrollment and dosing of in the certain ongoing Phase 2 trials.
These are the top analyst upgrades, downgrades and initiations from Wall Street on Tuesday, April 15, 2014. They include Citigroup, Equinix, IBM, Visa, Yahoo and Walmart.
Halozyme Therapeutics shares are getting pounded on Friday on news of a temporary halt of its Phase II trial enrollment and dosing for its pancreatic cancer study.
Once again, the analysts at Piper Jaffray are conducting extensive management meetings with the companies they cover. Here are the seven top biopharma stocks to buy now, according to Piper Jaffray.
Investors and traders are always on the lookout for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls to find great ideas from...
Source: ThinkstockMuch of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best known stocks from the S&P 500. These names are recognizable to...
Source: thinkstockHere are today’s five biggest gaining stocks at closing:Stereotaxis Inc. (NASDAQ: STXS) is up 30.2% at $2.33.Novogen Ltd. (NASDAQ: NVGN) is up 18.8% at $5.24.SemiLEDS Corp....
Source: thinkstockHere are today’s five biggest gaining stocks at closing:Top Ships Inc. (NASDAQ: TOPS) is up 39% at $1.39.Halozyme Therapeutics Inc. (NASDAQ: HALO) is up 31% at $6.90.Anacor...
U.S. equity markets opened lower this morning following last night’s failure by the U.S. House of Representatives to hold a vote on a plan to deal with the country’s budget deficit. In Europe,...
Source: Photo by Spencer Platt/Getty ImagesThe stock market is up Friday, with the Dow Jones Industrial Average up 0.33%, the Nasdaq up 0.59% and the S&P 500 up 0.43%. Today’s winners include a...
US equities opened higher this morning following the report on a US non-farm payroll gain of 227,000 jobs (more coverage here). In Europe, the Greek debt swap deal went off smoothly, but the...
The three major US equities indexes opened higher this morning on the news from Europe that the Greek debt swap deal would be a success. That prediction turned out to be solid, as about 80% of Greek...